The top executives of the global pharmaceutical industry are in Greece in the context of their biannual meeting, better known as the Biopharmaceutical CEOs Roundtable (BCR). They are the members of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), which represents more than 90 pharmaceuticals and associations around the world.

Their meeting is being held in Greece following the initiative of Albert Bourla of Pfizer, who, thanks to his Greek origin, is chairing this event. Prime Minister Kyriakos Mitsotakis will have meetings with 20 managing directors and five presidents of associations from the largest multinational biopharmaceutical groups worldwide on Tuesday and Wednesday.

Ηeads of Boehringer-Ingelheim, BMS, Johnson & Johnson, Novo Nordisk, Sanofi, Eli Lilly, Takeda, Menarini, Bayer and others will participate in the forum.

The focus is reportedly on the new investments of pharmaceutical companies in our country and the introduction of new innovative treatments.